published 30-day FRN

Federal Register / Vol. 85, No. 30 / Thursday, February 13, 2020 / Notices
will be removed when responses are
compiled.
This RFI is for planning purposes
only and should not be construed as a
solicitation for applications or
proposals, or as an obligation in any
way on the part of the United States
Federal government. The Federal
government will not pay for the
preparation of any information
submitted or for the government’s use.
Additionally, the government cannot
guarantee the confidentiality of the
information provided.
Dated: February 7, 2020.
Lawrence A. Tabak,
Principle Deputy Director, National Institutes
of Health.
[FR Doc. 2020–02918 Filed 2–12–20; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meeting

jbell on DSKJLSW7X2PROD with NOTICES

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Human
Genome Research Institute Initial Review
Group; Genome Research Review Committee.
Date: March 5, 2020.
Time: 11:30 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, 6700B Rockledge Drive, Jordan
Conf. Rm. (#2201), Bethesda, MD 20917
(Telephone Conference Call).
Contact Person: Rudy Pozzatti, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Human Genome Research
Institute, 6700B Rockledge Drive, Room
3184, Bethesda, MD 20817, (301) 402–0838,
pozzattr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)

VerDate Sep<11>2014

18:34 Feb 12, 2020

Jkt 250001

8309

Dated: February 7, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.

Dated: February 7, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.

[FR Doc. 2020–02859 Filed 2–12–20; 8:45 am]

[FR Doc. 2020–02861 Filed 2–12–20; 8:45 am]

BILLING CODE 4140–01–P

BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

National Institutes of Health

National Institutes of Health

National Human Genome Research
Institute; Notice of Closed Meetings

Submission for OMB Review; 30-Day
Comment Request; Generic Clearance
for the Collection of Qualitative
Feedback on Agency Service Delivery,
(National Cancer Institute)

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel; Genomic Resource.
Date: March 25, 2020.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, 6700B Rockledge Drive, Room
3188, Bethesda, MD 20817. (Telephone
Conference Call)
Contact Person: Keith McKenney, Ph.D.,
Scientific Review Officer, National Human
Genome Research Institute, National
Institutes of Health, 6700B Rockledge Drive,
Room 3188, Bethesda, MD 20817, (301) 594–
4280, mckenneyk@mail.nih.gov.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel; Genome Innovator.
Date: March 26, 2020.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, 6700B Rockledge Drive, Room
3180, Bethesda, MD 20817. (Telephone
Conference Call)
Contact Person: Ken D. Nakamura, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, Room 3180, Bethesda, MD
20817, (301) 402–0838, nakamurk@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)

PO 00000

Frm 00065

Fmt 4703

Sfmt 4703

AGENCY:

National Institutes of Health,

HHS.
ACTION:

Notice.

In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30-days of the date of this
publication.
SUMMARY:

Written comments and/or
suggestions regarding the item(s)
contained in this notice, especially
regarding the estimated public burden
and associated response time, should be
directed to the: Office of Management
and Budget, Office of Regulatory Affairs,
OIRA_submission@omb.eop.gov or by
fax to 202–395–6974, Attention: NIH
Desk Officer.
FOR FURTHER INFORMATION CONTACT:
Diane Kreinbrink, Office of Management
Policy and Compliance, National Cancer
Institute, 9609 Medical Center Drive,
Bethesda, MD 20892–9760 or call nontoll-free number (240) 276–5582 or
Email your request, including your
address to: diane.kreinbrink@nih.gov.
SUPPLEMENTARY INFORMATION: This
proposed information collection was
previously published in the Federal
Register on December 3, 2019, page
66209 (Vol. 84, No. 232 FR 66209) and
allowed 60 days for public comment.
One public comment was received. The
purpose of this notice is to allow an
additional 30 days for public comment.
The National Cancer Institute (NCI),
National Institutes of Health, may not
conduct or sponsor, and the respondent
is not required to respond to, an
information collection that has been
extended, revised, or implemented on or
ADDRESSES:

E:\FR\FM\13FEN1.SGM

13FEN1

8310

Federal Register / Vol. 85, No. 30 / Thursday, February 13, 2020 / Notices

after October 1, 1995, unless it displays
a currently valid OMB control number.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below.
Proposed Collection: Generic
Clearance for the Collection of
Qualitative Feedback on Agency Service
Delivery (NCI), 0925–0642,
EXTENSION, National Cancer Institute

on areas where communication, training
or changes in operations might improve
delivery of products or services. It also
allows feedback to contribute directly to
the improvement of program
management. Feedback collected under
this generic clearance provides useful
information but it will not yield data
that can be generalized to the overall
population.
OMB approval is requested for 3 year.
There are no costs to respondents other
than their time. The total estimated
annualized burden hours are 9,337.

(NCI), National Institutes of Health
(NIH).
Need and Use of Information
Collection: This information collection
activity is collecting qualitative
customer and stakeholder feedback in
an efficient, timely manner, in
accordance with the Administration’s
commitment to improving service
delivery. This generic provides
information about the National Cancer
Institute’s customer or stakeholder
perceptions, experiences and
expectations, provide an early warning
of issues with service, or focus attention

ESTIMATED ANNUALIZED BURDEN HOURS

Surveys .................................................................
In-Depth Interviews (IDIs) or Small Discussion
Groups.
Focus Groups .......................................................
Website or Software Usability Tests ....................

Individuals .....................
Individuals .....................

27,100
500

1
1

12/60
90/60

5,420
750

Individuals .....................
Individuals .....................

1000
5000

1
1

90/60
20/60

1,500
1,667

Total ...............................................................

.......................................

........................

33,600

........................

9,337

BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Request for Information (RFI): Inviting
Comments and Suggestions on a
Framework for the NIH-Wide Strategic
Plan for FYs 2021–2025
AGENCY:

National Institutes of Health,

HHS.
ACTION:

Notice.

This Request for Information
(RFI) is intended to gather broad public
input to assist the National Institutes of
Health (NIH) in developing the NIHWide Strategic Plan for Fiscal Years
(FYs) 2021–2025. NIH invites input
from stakeholders throughout the
scientific research, advocacy, and
clinical practice communities, as well as
the general public, regarding the
proposed framework for the FY 2021–
2025 NIH-Wide Strategic Plan.
Organizations are strongly encouraged
to submit a single response that reflects
the views of their organization and their
membership as a whole.

SUMMARY:

VerDate Sep<11>2014

18:34 Feb 12, 2020

Jkt 250001

This RFI is open for public
comment for a period of 6 weeks.
Comments must be received by 11:59:59
p.m. (ET) on March 25, 2020 to ensure
consideration.
ADDRESSES: All comments must be
submitted electronically on the
submission website, available at https://
grants.nih.gov/grants/rfi/rfi.cfm?ID=101.
FOR FURTHER INFORMATION CONTACT:
Please direct all inquiries to: Marina
Volkov, nihstrategicplan@od.nih.gov,
301.496.4147.
DATES:

[FR Doc. 2020–02913 Filed 2–12–20; 8:45 am]

jbell on DSKJLSW7X2PROD with NOTICES

Average
burden
per response
(in hours)

Type of
respondent

Dated: February 5, 2020.
Diane Kreinbrink,
Project Clearance Liaison, National Cancer
Institute, National Institutes of Health.

Number of
respondents

Number of
responses per
respondent

Form name

The
purpose of the NIH-Wide Strategic Plan
is to communicate how NIH will
advance its mission to support research
in pursuit of fundamental knowledge
about the nature and behavior of living
systems, and the application of that
knowledge to enhance health, lengthen
life, and reduce illness and disability.
The current NIH-Wide Strategic Plan
(available at: https://www.nih.gov/
about-nih/nih-wide-strategic-plan),
covering FYs 2016–2020, was submitted
to Congress on December 15, 2015. As
part of implementing the 21st Century
Cures Act (Pub. L. 114–255), NIH will
update its Strategic Plan every five
years. The agency is currently
developing an updated NIH-Wide
Strategic Plan, for FYs 2021–2025, and
anticipates releasing it in December
2020.
The FY 2021–2025 NIH-Wide
Strategic Plan will highlight NIH’s

SUPPLEMENTARY INFORMATION:

PO 00000

Frm 00066

Fmt 4703

Sfmt 4703

Total annual
burden hours

approach towards the achievement of its
mission while ensuring good
stewardship of taxpayer funds. It is not
intended to outline the myriad of
important research opportunities for
specific diseases or conditions. Nor will
it focus on the specific research
missions of each component Institute,
Center and Office. Those opportunities
are found within strategic plans that are
specific to an Institute, Center, or Office,
or specific to a particular disease or
disorder. (A list of Institute, Center, or
Office-specific, topical, and other NIHwide or interagency strategic plans is
available at https://report.nih.gov/
strategicplans/.)
The Framework for the FY 2021–2025
NIH-Wide Strategic Plan, below,
articulates NIH’s priorities in three key
areas (Objectives): Biomedical and
behavioral science research; scientific
research capacity; and scientific
integrity, public accountability, and
social responsibility in the conduct of
science. These Objectives apply across
NIH. In addition, several Cross-Cutting
Themes, which span the scope of these
Objectives, are identified.
NIH-Wide Strategic Plan Framework
Cross Cutting Themes
• Increasing, Enhancing, and
Supporting Diversity
• Improving Women’s Health and
Minority Health, and Reducing Health
Disparities

E:\FR\FM\13FEN1.SGM

13FEN1